JP5890846B2 - ポリフェノールの新規合成方法 - Google Patents

ポリフェノールの新規合成方法 Download PDF

Info

Publication number
JP5890846B2
JP5890846B2 JP2013551012A JP2013551012A JP5890846B2 JP 5890846 B2 JP5890846 B2 JP 5890846B2 JP 2013551012 A JP2013551012 A JP 2013551012A JP 2013551012 A JP2013551012 A JP 2013551012A JP 5890846 B2 JP5890846 B2 JP 5890846B2
Authority
JP
Japan
Prior art keywords
formula
compound
group
epicatechin
chloride
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2013551012A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014509312A (ja
JP2014509312A5 (cg-RX-API-DMAC7.html
Inventor
スンディープ デュガル
スンディープ デュガル
ディネシュ マハジャン
ディネシュ マハジャン
パンテリス ピーター ジャンヌーシス
パンテリス ピーター ジャンヌーシス
ヴィジャイ シン
ヴィジャイ シン
カマル キショア カプール
カマル キショア カプール
Original Assignee
スファエラ ファーマ ピーティーイー リミテッド
スファエラ ファーマ ピーティーイー リミテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by スファエラ ファーマ ピーティーイー リミテッド, スファエラ ファーマ ピーティーイー リミテッド filed Critical スファエラ ファーマ ピーティーイー リミテッド
Publication of JP2014509312A publication Critical patent/JP2014509312A/ja
Publication of JP2014509312A5 publication Critical patent/JP2014509312A5/ja
Application granted granted Critical
Publication of JP5890846B2 publication Critical patent/JP5890846B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/74—Benzo[b]pyrans, hydrogenated in the carbocyclic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/28—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
    • C07D311/30—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only not hydrogenated in the hetero ring, e.g. flavones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/60—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with aryl radicals attached in position 2
    • C07D311/62—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with aryl radicals attached in position 2 with oxygen atoms directly attached in position 3, e.g. anthocyanidins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Vascular Medicine (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pyrane Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
JP2013551012A 2011-01-27 2012-01-24 ポリフェノールの新規合成方法 Expired - Fee Related JP5890846B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN196/DEL/2011 2011-01-27
IN196DE2011 2011-01-27
PCT/IN2012/000052 WO2012101652A2 (en) 2011-01-27 2012-01-24 A novel process for synthesis of polyphenols

Publications (3)

Publication Number Publication Date
JP2014509312A JP2014509312A (ja) 2014-04-17
JP2014509312A5 JP2014509312A5 (cg-RX-API-DMAC7.html) 2015-03-19
JP5890846B2 true JP5890846B2 (ja) 2016-03-22

Family

ID=46581222

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013551012A Expired - Fee Related JP5890846B2 (ja) 2011-01-27 2012-01-24 ポリフェノールの新規合成方法

Country Status (7)

Country Link
US (1) US9428482B2 (cg-RX-API-DMAC7.html)
EP (1) EP2668176B1 (cg-RX-API-DMAC7.html)
JP (1) JP5890846B2 (cg-RX-API-DMAC7.html)
CN (1) CN103582635B (cg-RX-API-DMAC7.html)
ES (1) ES2636441T3 (cg-RX-API-DMAC7.html)
TW (1) TWI697489B (cg-RX-API-DMAC7.html)
WO (1) WO2012101652A2 (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6411375B2 (ja) * 2013-01-26 2018-10-24 スファエラ ファーマ プライベート リミテッド カテキンの新規合成手法
EP2981260B1 (en) * 2013-04-04 2021-01-13 Sphaera Pharma Pvt. Ltd. Novel analogues of epicatechin and related polyphenols
EP3795578A3 (en) 2014-07-23 2021-05-26 Sphaera Pharma Pvt. Ltd. Hydroxysteroid compounds, their intermediates, process of preparation, composition and uses thereof
US10898465B2 (en) 2016-06-21 2021-01-26 Epirium Bio Inc. Utility of (+) epicatechin and their analogs
CN105949161B (zh) * 2016-06-28 2018-05-15 温州大学 一种3-芳巯基黄酮化合物的制备方法
CN106946835B (zh) * 2017-04-25 2019-03-01 广州科技职业技术学院 橙皮素酯化物及其制备方法和应用
WO2019044672A1 (ja) * 2017-08-28 2019-03-07 株式会社Ｎｂｃメッシュテック ポリフェノールの製造方法
BR112021007684A2 (pt) 2018-10-24 2021-07-27 Epirium Bio Inc. cocristal, composição farmacêutica, métodos para tratar uma doença ou distúrbio que se beneficiaria da modificação da cadeia de transporte de elétrons, para reduzir os níveis de triglicerídeos, para tratar uma doença ou distúrbio selecionado a partir do grupo que consiste em uma síndrome metabólica, diabetes tipo ii, uma hiperlipidemia congênita e hiperlipidemia induzida por drogas, para tratar uma condição relacionada à disfunção mitocondrial, para melhorar o desempenho esportivo, resistência, construção de forma ou força muscular, ou facilitar a recuperação dos efeitos do treinamento ou competição e para tratar ou prevenir distrofinopatia, sarcoglicanopatia ou disferlinopatia, processo para preparar um cocristal, e, uso de um cocristal

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2122608B (en) * 1982-06-01 1985-10-02 Zyma Sa (+)-cyanidan-3-ol derivatives
DE69132694T2 (de) * 1990-03-08 2002-06-20 Fuji Photo Film Co., Ltd. Positiv arbeitende Photolackzusammensetzung
US6476241B1 (en) 2000-09-05 2002-11-05 Mars Incorporated Synthesis of 4α-arylepicatechins
JPWO2004078741A1 (ja) * 2003-03-03 2006-06-08 三栄源エフ・エフ・アイ株式会社 アディポネクチン発現促進剤
JP5339664B2 (ja) * 2004-02-13 2013-11-13 花王株式会社 Ａｍｐｋ活性化剤
JP2006083105A (ja) * 2004-09-16 2006-03-30 Ito En Ltd 血液流動性改善剤および飲食物
CA2612438A1 (en) * 2005-06-29 2007-01-04 Mars, Incorporated Preparation of (+)-catechin, (-)-epicatechin, (-)-catechin, (+)-epicatechin, and their 5,7,3',4'-tetra-o-benzyl analogues
EP2167043A4 (en) * 2007-06-06 2013-05-01 Univ South Florida NEW USE CO-CRYSTAL COMPOSITIONS
JP5382676B2 (ja) * 2007-12-07 2014-01-08 国立大学法人名古屋大学 アントシアニジン類の製造方法

Also Published As

Publication number Publication date
EP2668176B1 (en) 2017-05-17
US9428482B2 (en) 2016-08-30
EP2668176A2 (en) 2013-12-04
TWI697489B (zh) 2020-07-01
JP2014509312A (ja) 2014-04-17
ES2636441T8 (es) 2018-12-14
ES2636441T3 (es) 2017-10-05
WO2012101652A3 (en) 2012-12-27
WO2012101652A2 (en) 2012-08-02
US20140031421A1 (en) 2014-01-30
CN103582635A (zh) 2014-02-12
EP2668176A4 (en) 2014-08-27
CN103582635B (zh) 2019-02-19
TW201309662A (zh) 2013-03-01

Similar Documents

Publication Publication Date Title
JP5890846B2 (ja) ポリフェノールの新規合成方法
US7906660B2 (en) Production of isoflavone derivatives
JP7039643B2 (ja) カテキンの新規合成手法
KR101829102B1 (ko) 크로마논 2-카르복실산 유도체, 크로만 2-카르복실산 유도체 및 이의 제조방법
ES2553266T3 (es) Proceso para la preparación de nebivolol
JP5744738B2 (ja) ネビボロールの調製方法
AU2009231345B2 (en) Process for preparing Nebivolol
JP5780651B2 (ja) エクオールの不斉合成法
JP2018070509A (ja) 新規トコフェリルアスコルビン酸誘導体とその製造方法
CN105358540A (zh) 在脲或硫脲的存在下使用手性吡咯烷来形成手性4-苯并二氢吡喃酮
US20090099374A1 (en) Method for producing flavan derivative
EA030593B1 (ru) Получение хиральных 4-хроманонов с применением хиральных пирролидинов в присутствии фенолов или тиофенолов

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20150126

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20150126

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20150806

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20150817

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20151117

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20160120

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20160219

R150 Certificate of patent or registration of utility model

Ref document number: 5890846

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees